ClinicalTrials.gov record
Recruiting No phase listed Observational

Intervascular Post-Market Clinical Follow-Up (PMCF) Registry

ClinicalTrials.gov ID: NCT07322913

Public ClinicalTrials.gov record NCT07322913. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 4:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Post-Market Clinical Follow-up Registry to Evaluate the Safety and Performance of the Intervascular Vascular Grafts and Patches in Patients Undergoing Bypass, Replacement, or Repair of Aortic, Peripheral, or Carotid Arteries

Study identification

NCT ID
NCT07322913
Recruitment status
Recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
Intervascular
Industry
Enrollment
1,200 participants

Conditions and interventions

Interventions

  • Hemashield - Collagen Coated Vascular Grafts and Patches Device
  • Intergard Silver - Antimicrobial Collagen Coated Vascular Grafts and Patches Device
  • Intergard Standard - Collagen Coated Vascular Grafts and Patches Device
  • Intergard Synergy - Antimicrobial Collagen Coated Vascular Grafts Device

Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 18, 2025
Primary completion
Nov 30, 2026
Completion
Nov 30, 2026
Last update posted
Mar 11, 2026

2025 – 2026

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Allegheny General Hospital Pittsburgh Pennsylvania 15212 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07322913, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 11, 2026 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07322913 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →